Café com Ciência: "Recent advances in formulation and manufacturing of nanomedicines"
Sexta-feira, dia 06/10, às 12:40 hs, no anfiteatro II do IF-UFG, teremos um Café com Ciência Duplo com a participação dos pesquisadores europeus Dr. Adam Bohr e Dr. Korbinian Löbmann. Os palestrantes irão discutir sobre o tema "Recent advances in formulation and manufacturing of nanomedicines". Venha aprender e discutir sobre o impacto da Nanomedicina na Saúde.
Café com Ciência: Recent advances in formulation and manufacturing of nanomedicines
Data: 06/10 (sexta-feira)
Horário: 12:40 hs
Local: Anfiteatro II do IF/UFG (prédio antigo)
Palestrantes: Prof. Dr. Korbinian Löbmann e Prof. Dr. Adam Bohr
Instituição: University of Copenhagen, Denmark
Informações adicionais:
Adam’s research interest include particle engineering, from fundamentals to therapeutic application. Engineering of drug-loaded nano- and microparticles with specific attributes using techniques such as microfluidics, electrospraying and spray drying. Investigation of particle formation processes via experimental and numerical methods. Pharmaceutical formulation design for pulmonary and oral administration. Formulation of poorly stable drugs such as siRNA, peptides and proteins using novel drug delivery and manufacturing technologies including microfluidics and 3D printing.
Korbinian Löbmann received his PhD degree from the University of Otago, Dunedin, New Zealand in 2013. After a short postdoctoral period of 5 month at the University of Copenhagen, he then obtained a position as Assistant Professor at the Department of Pharmacy, University of Copenhagen, Denmark in September 2013. His research interests are in formulation and physical characterization of solid drug delivery systems and in particular the development of enabling formulations for poorly water-soluble drugs. These include amorphous and in particular co-amorphous drug delivery systems as well as formulation strategies using novel excipients such as PEGosomes, cellulose nanofibers (CNF) and deep eutectic solvents (DES). The research aims to improve drug therapy and efficacy through appropriate formulation of medicines.